BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 27406391)

  • 1. Six controversial issues on subclinical Cushing's syndrome.
    Chiodini I; Albani A; Ambrogio AG; Campo M; De Martino MC; Marcelli G; Morelli V; Zampetti B; Colao A; Pivonello R;
    Endocrine; 2017 May; 56(2):262-266. PubMed ID: 27406391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do the diagnostic criteria for subclinical hypercortisolism exist?
    Tabarin A
    Ann Endocrinol (Paris); 2018 Jun; 79(3):146-148. PubMed ID: 29661471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical Cushing's syndrome.
    Terzolo M; Reimondo G; Bovio S; Angeli A
    Pituitary; 2004; 7(4):217-23. PubMed ID: 16132200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
    Mazzuco TL; Bourdeau I; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):203-10. PubMed ID: 19390321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of overt Cushing's syndrome in patients with adrenal incidentaloma.
    Barzon L; Fallo F; Sonino N; Boscaro M
    Eur J Endocrinol; 2002 Jan; 146(1):61-6. PubMed ID: 11751069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Cushing's syndrome in adrenal incidentalomas.
    Sippel RS; Chen H
    Surg Clin North Am; 2004 Jun; 84(3):875-85. PubMed ID: 15145240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
    Nunes ML; Vattaut S; Corcuff JB; Rault A; Loiseau H; Gatta B; Valli N; Letenneur L; Tabarin A
    J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subclinical Cushing's syndrome in adrenal incidentalomas].
    Bovio S; Reimondo G; Daffara F; Allasino B; Angeli A; Terzolo M
    Recenti Prog Med; 2006 Jan; 97(1):6-15. PubMed ID: 16535924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When to Intervene for Subclinical Cushing's Syndrome.
    Hsieh LB; Mackinney E; Wang TS
    Surg Clin North Am; 2019 Aug; 99(4):747-758. PubMed ID: 31255204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical Cushing's syndrome: current concepts and trends.
    Zografos GN; Perysinakis I; Vassilatou E
    Hormones (Athens); 2014; 13(3):323-37. PubMed ID: 25079456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
    Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Cushing's syndrome in adrenal incidentalomas.
    Terzolo M; Bovio S; Reimondo G; Pia A; Osella G; Borretta G; Angeli A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):423-39, x. PubMed ID: 15850851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
    Kuzu I; Zuhur SS; Demir N; Aktas G; Yener Ozturk F; Altuntas Y
    Endokrynol Pol; 2016; 67(5):487-492. PubMed ID: 26884297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the Patient with Subclinical Cushing's Syndrome.
    Ivović M; Marina LV; Šojat AS; Tančić-Gajić M; Arizanović Z; Kendereški A; Vujović S
    Curr Pharm Des; 2020; 26(43):5584-5590. PubMed ID: 32787757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Cushing's syndrome.
    De Leo M; Cozzolino A; Colao A; Pivonello R
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):497-505. PubMed ID: 22863391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subclinical Cushing's syndrome in populations at risk].
    Caetano MS; Vilar L; Kater CE
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1185-90. PubMed ID: 18209855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical hypercortisolism in adrenal incidentaloma.
    Debono M; Newell-Price J
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):185-92. PubMed ID: 25871961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome.
    Tsuiki M; Tanabe A; Takagi S; Naruse M; Takano K
    Endocr J; 2008 Aug; 55(4):737-45. PubMed ID: 18506093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.